Specialty Pharmacy News | Specialty Pharmacy Industry | Avella Blog

Thu, Jan 9, 2020

How Gene Therapy Will Change Cancer Treatment

The latest advances in oncology and gene therapy research are presenting new ways of fighting cancer. One of those is gene therapy, which the U.S. National Library of Medicine defines as an experimental technique that uses genes to treat and prevent ...

Tue, Oct 1, 2019

National Rare Cancer Day

Approximately 1 in 5 people with cancer in the U.S. are diagnosed with rare cancer. Although there is no universal definition, the National Cancer Institute defines rare cancers as fewer than 15 cases per 100,000 people per year. Other experts feel ...

Fri, May 25, 2018

Know Your Next Steps: Testing for the T790M Gene Mutation in EGFR+, Metastatic Non-Small Cell Lung Cancer

If you or a loved one has been diagnosed with EGFR positive, metastatic non-small cell lung cancer (NSCLC), you’re already facing a lot of decisions. These may include what type of treatment will work best for you. You and your doctor can work ...

Fri, Mar 23, 2018

3 Ways the New IMBRUVICA® Formulation Will Have a Big Impact on Patients

In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...

Fri, Mar 9, 2018

Avella Releases Latest Issue of Dispensing Excellence, Oncology Edition

In today’s oncology landscape, new oral chemotherapy medications or updated indications are being released at an increasing rate. With each approval comes new hope for individuals and their families for a road to remission, and also a ...

Fri, Apr 21, 2017

Outlook on Oncology: Trends, Technology & Trials in Cancer Care

Would you be surprised to hear that two out of three people with invasive cancer are living 5 years or longer -- nearly 30% more than 49% in 1975? Clinical trial activity for oncology research also climbed more than 10% last year. Cancer care these ...

Fri, Mar 17, 2017

503A Services: Your Source for Patient-Specific Compounded Medications

503A is a section of the Federal Food, Drug, and Cosmetic Act that regulates pharmacy compounding practices. Generally, 503A refers to “traditional” pharmacy compounding and specifies when traditional compounding pharmacies are permitted to compound ...

Fri, Feb 10, 2017

Cancer Prevention Month: 3 Ways to Know Your Risk & Help You Prevent Cancer

The American Cancer Society recognizes February as National Cancer Prevention Month. In honor of this month, we are sharing three ways you and your family can help reduce your risk of cancer or detect cancer earlier. Let's start with the simple ...

Thu, Dec 15, 2016

Avella Specialty Pharmacy Acquires Oncology Plus

We are excited to announce that Avella has recently acquired Oncology Plus, LLC, a leading provider of patient-specific compounded therapies to oncology practices, hospitals and payors nationwide. With this acquisition, Avella furthers its strategic ...

Fri, Oct 7, 2016

Improve Adherence with Smart Pill Bottles for Patients Taking Certain Oral Oncolytics Medications

According to the Network for Excellence in Health Innovation, in the United States, poor medication adherence alone accounts for $290 billion of the annual $750 billion in wasted healthcare spend. In addition, medication non-adherence with complex ...